Trent Gordon

Biotech Strategy Consultant - passionate endurance athlete . 🇨🇦 living in 🇺🇸

[Bruce Booth @LifeSciVC]

And so it begins... The great battle of our time … for investor mindshare in what will likely be a lot of IPOs in 1H 2026

[Pearl Freier @PearlF]

An updated FDA org chart from @biospace: nearly 90% of senior leaders who were at the FDA a year ago are no longer there. Most FDA employees are usually "career staff" who worked for multiple FDA commissioners & years of training to be knowledgeable incl cell & gene therapies. Pazdur had worked for the Bush, Obama, Trump 1 & Biden administrations. He wasn't a Biden appointee

[Trent Gordon @Flash_Gordon96]

@theryandreyer Averaged 161 spm at the St George marathon to run a 2:59:04. Downhill course though, so not sure if it counts. 6’3 with mediocre running form.

[MLB @MLB]

THE TORONTO @BLUEJAYS ARE HEADING TO THEIR FIRST WORLD SERIES IN 32 YEARS 😤 #CLINCHED

[Trent Gordon @Flash_Gordon96]

@ruima @BowTiedBiotech Top 20 deals so far - I imagine upfront deal value will only get bigger in the next few years

[Trent Gordon @Flash_Gordon96]

Would love to hear everyone’s thoughts on the space, and the future of US drug development!

[Trent Gordon @Flash_Gordon96]

Thrilled to share our latest insights on the surge in US-China biotech dealmaking! 🌍💊 We dive into the why, the who, and the how—plus what it means for the future of drug development. Don’t miss it! 🚀 #Biotech #Innovation”

[Trent Gordon @Flash_Gordon96]

While Merck has offered the most money, with the majority tied up in milestones

[Trent Gordon @Flash_Gordon96]

@megtirrell And maybe one day Parkinson’s? https://t.co/i1tV9K2UfH

But seriously, given the underlying implications of metabolism on nearly every disease, I see a future where GLP-1s are prescribed more than statins

[Trent Gordon @Flash_Gordon96]

@JoePompliano Asics Novablast 4! The entire Novablast series feels like you are running on clouds. By far the most comfortable running shoe I have used. Insanely fun to use.

[Trent Gordon @Flash_Gordon96]

@bradloncar @BiotechTVHQ This is fantastic! Congratulations Brad!

[Trent Gordon @Flash_Gordon96]

If you enjoyed these insights, checkout our full analysis of the transactional landscape surrounding #ADCs https://t.co/rCpz98absN #pfizer #seagen #merck

[Trent Gordon @Flash_Gordon96]

Pfizer buying Seagen for $43B today… but what drove that deal Value?? Seagen is a leader in developing antibody drug conjugates #ADCs, which have commended the highest deal value of any modality in oncology #pfizer #seagen

[Trent Gordon @Flash_Gordon96]

What is really interesting about ADCs is that they are incredibly hard to manufacture, so there is reduced likelihood that revenue will eaten away by biosimilar competition… Thus ADC developers can keep bringing in blockbuster revenue potentially beyond the typical patent life